
Public Health
Latest News
Latest Videos

CME Content
More News

While experts have been measuring the impacts stemming from US pharmacy deserts, they are also working to establish a path forward to reduce closures and increase access.

Integrating health-related social needs programs into pharmacy practice strengthens patient care and positions pharmacies as vital public health partners.

Pharmacists leverage socioeconomic insights to combat health disparities, enhancing access to medications and public health services in underserved communities.

Samantha Picking, PharmD, senior director of immunizations at Walgreens, discusses how pharmacists have emerged as the ideal providers to manage vaccine administration.

Pharmacists and dietitians acknowledge that older adults and patients with misconceptions about or poor knowledge of diet should be screened for interventions.

Understanding post-PREP implications is critical for evaluating current public health delivery, identifying ongoing access, and informing future policy.

Michael Murphy, PharmD, MBA, discusses the increasingly prominent impacts of pharmacy deserts, highlighting discrepancies in the term's definition and the financial pressures impacting sustainability.

Amid uncertainty about the best factors for measuring and defining pharmacy deserts, researchers explored the impacts of drive time and inequities in pharmacy access.

Michael Murphy, PharmD, MBA, provided insights on his research regarding pharmacy deserts, who they impact the most, and the methods needed to improve them in the US.

Researchers addressed the current trends in prescription drug use and spending among Medicare Advantage beneficiaries during the first year of clinician access to a real-time prescription benefit tool.

Our whole country needs to do better in providing harm reduction services, including naloxone and syringe service programs.

Pharmacy team members can help patients prepare for upcoming travels, ensuring they are up to date with the recommended vaccines for their locations.

In a session at PQA 2025, presenters discussed the impact of SDoH on health outcomes and how pharmacy teams can identify and address barriers.

Health care economist Marta Wosinska, PhD, senior fellow with The Brookings Institution, discussed the potential impact pharmaceutical tariffs may have on access to generic and brand-name drugs.

Marta Wosinska, PhD, senior fellow with The Brookings Institution, discussed her ongoing research regarding the potential impact of pharmaceutical tariffs on the prescription drug market.

Currently under development, the manufacturer’s investigational pandemic influenza vaccine is designed to target the H5 avian influenza virus, or bird flu.

The use of the terminology can alter the meaning when assigned to patients’ behaviors, unintentionally implying that barriers such as poverty or systemic racism are due to poor behavior or efforts.

Amid record levels of advertisements for lifestyle medications on social media, Luke Turnock, PhD, discusses the global impact these trends may have on patients.

Luke Turnock, PhD, MSc, discussed current trends in the promotion of lifestyle enhancement drugs for populations they are not approved for.

Throughout her research, Jenny Markell, BA, has uncovered some alarming trends within prescription drug advertising in the US.

In part 3 of our interview with Jenny Markell, BA, she discussed drug advertising trends among Alzheimer’s disease drugs and how FDA suggestions are not necessarily followed.

Jenny Markell, BA, discussed the ongoing trends in prescription drug advertising and touched on her research into the impact it has on consumers.

A HealthDay Harris Poll highlights the most recent feelings patients have towards vaccines amid outbreaks of vaccine-preventable illness and changes at the federal level impacting public health policy.

Jenny Markell, BA, joined us to discuss the nuances of drug promotion in the US and how specific medications are targeted to various patient populations.

Jeffrey Bratberg, PharmD and Madi Hartling, a 2025 PharmD candidate, discuss the lack of pharmacists in medical shows and how pharmacists are typically portrayed negatively in media.







































































